17,27-Hentriacontadiene-2,4,6,30-tetrayne-1,8,- 29-triol,(8S,17Z,27E,29R)- (182314-05-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 17,29-Tritriacontadiene-2,4,6,32-tetrayne-1,8,31-triol,(8S,17Z,29E,31R)-
- 1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
- 1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
- 1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
- 6-Oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.15,8.112,15]triaconta-5(30),12(29),14,25(28),27-pentaene-2,9,16,19,22-pentone,21-[(1R)-1-hydroxyethyl]-7,24-dimethyl-18-[(1S)-1-methylpropyl]-4-(2-methylpropyl)-11-(phenylmethyl)-,(4S,7R,8S,11R,18S,21S,24R)-
- 1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
- 1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
- 16,28-Dotriacontadiene-2,4,6,31-tetrayne-1,8,- 30-triol,(8S,16Z,28E,30R)-
- 4,17,27-Hentriacontatriene-2,20,30-triynoicacid, 29-hydroxy-, (4Z,17Z,27E)-
- 4,17,27-Hentriacontatriene-2,20,30-triynoicacid, 29-hydroxy-, (4E,17Z,27E)-
- 6-Oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.15,8.112,15]triaconta-5(30),12(29),14,25(28),27-pentaene-2,9,16,19,22-pentone,21-[1-(formyloxy)ethyl]-7,11-dimethyl-18-(1-methylpropyl)-4-(2-methylpropyl)-24-(phenylmethyl)-(9CI)
- (4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
- Pentacyclo[21.3.1.13,7.110,14.116,20]triaconta-1(27),- 3,5,7(30),10,12,14(29),16,18,20(28),23,25- dodecaene
- (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
- 5,9,11,14,17,20-Triacontahexaene-3,8,28-triol,2,29-diamino-, (2R,3S,5Z,9E,11Z,14Z,17Z,20Z,28S,29R)-
- 23,37-Hentetracontadiene-2,4,6,40-tetrayne-1,8,39-triol,(8S,23Z,37E,39R)-
- Peptide F (cattleadrenal medulla),1-de-L-tyrosine-2-deglycine-3-deglycine-4-de-L-phenylalanine-5-de-L-methionine-6-de-L-lysine-7-de-L-lysine-26-L-leucinamide-27-deglycine-28-de-L-lysine-29-de-L-arginine-30-de-L-tyrosine-31-deglycine-32-deglycine-33-de-L-phenylalanine-34-de-L-methionine-(9CI)
- Bicyclo[12.12.4]triaconta-1(27),2,4,10,12,14(30),15,17,23,25,27,28,29-tridecaene-6,8,19,21-tetrayne, 5,10,18,23-tetrakis(1,1-dimethylethyl)-,(E,E,E,E,Z,Z,Z,Z)-
- 17,28-Dotriacontadiene-2,4,6,15,31-pentayne-1,8,30-triol,(8S,17Z,28E,30R)-
- 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14